Preventing Recurrent Clostridioides difficile Infections with Fecal Microbiota-Based Therapies
home / peer-exchange / preventing-recurrent-clostridioides-difficile-infections-with-fecal-microbiota-based-therapies
A panel of experts has a comprehensive discussion on Clostridioides difficile infections, focusing on characteristics of the disease, treatment practices, clinical trial data, and new fecal microbiome-based therapies.
EP. 1: Epidemiology of C. difficile Infections in the US
Paul Feuerstadt, MD;Carl V. Crawford, MD;Sahil Khanna, MBBS, MS;Teena Chopra, MD, MPH;Matthew D. Sims, MD, PhD, FACP, FIDSA
August 26th 2024A panel of experts provide an overview of the epidemiology of Clostridioides difficile infections, highlighting diagnostic practices and the role of antimicrobial stewardship.
Watch
